<code id='69030FB0C9'></code><style id='69030FB0C9'></style>
    • <acronym id='69030FB0C9'></acronym>
      <center id='69030FB0C9'><center id='69030FB0C9'><tfoot id='69030FB0C9'></tfoot></center><abbr id='69030FB0C9'><dir id='69030FB0C9'><tfoot id='69030FB0C9'></tfoot><noframes id='69030FB0C9'>

    • <optgroup id='69030FB0C9'><strike id='69030FB0C9'><sup id='69030FB0C9'></sup></strike><code id='69030FB0C9'></code></optgroup>
        1. <b id='69030FB0C9'><label id='69030FB0C9'><select id='69030FB0C9'><dt id='69030FB0C9'><span id='69030FB0C9'></span></dt></select></label></b><u id='69030FB0C9'></u>
          <i id='69030FB0C9'><strike id='69030FB0C9'><tt id='69030FB0C9'><pre id='69030FB0C9'></pre></tt></strike></i>

          explore

          explore

          author:focus    Page View:124
          microbiome runners
          Adobe

          Elite athletes really are different from you and me. Or, at least their gut microbes are.

          Scientists who analyzed stool samples of 15 runners a week before and after they competed in the 2015 Boston Marathon found unusually high levels of one particular microbe compared to 10 non-athletes. Levels of the microbe in question, Veillonella, spiked after an intense workout and bloomed even more after the marathon.

          advertisement

          That was a lightbulb moment for the scientists because the bacterium is known for breaking down and eating lactate, a metabolite even ordinary runners equate with fatigue.  

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more
          Sanofi says it has 12 blockbusters on the way. Will investors believe it?
          Sanofi says it has 12 blockbusters on the way. Will investors believe it?

          SanofiCEOPaulHudsonCourtesySanofiNEWYORK—ThetopexecutivesatFrenchdruggiantSanofionWednesdaydefendedt

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          Scientists inch closer to single

          AdobeWhatisthebestwaytofixfaultybloodcells,anddosoforthemostpeople?That’sthequestionahordeofgeneedit